169 related articles for article (PubMed ID: 30904166)
1. New research directions in medulloblastoma.
Grill J; Dufour C; Guerrini-Rousseau L; Ayrault O
Neurochirurgie; 2021 Feb; 67(1):87-89. PubMed ID: 30904166
[TBL] [Abstract][Full Text] [Related]
2. New concepts in organ site research on medulloblastoma: genetics and genomics.
Roussel MF
Future Oncol; 2010 Aug; 6(8):1229-31. PubMed ID: 20799868
[TBL] [Abstract][Full Text] [Related]
3. Are molecular subgroups of medulloblastomas really prognostic?
Frappaz D; Faure-Conter C; Meyronet D; Levard-Bonneville A; Beuriat PA; Sunyach MP; Barritault M
Curr Opin Neurol; 2018 Dec; 31(6):747-751. PubMed ID: 30300240
[TBL] [Abstract][Full Text] [Related]
4. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
5. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
Gupta T; Shirsat N; Jalali R
Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
[TBL] [Abstract][Full Text] [Related]
6. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
[No Abstract] [Full Text] [Related]
7. [Childhood medulloblastoma].
Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment.
Tamayo-Orrego L; Charron F
F1000Res; 2019; 8():. PubMed ID: 31700613
[TBL] [Abstract][Full Text] [Related]
9. Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics.
Yang H; Li M; Deng Y; Wen H; Luo M; Zhang W
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23233. PubMed ID: 38607297
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors of adult medulloblastomas: A review of the literature and perspectives].
Riffaud L; Hénaux PL
Neurochirurgie; 2016 Feb; 62(1):46-52. PubMed ID: 26657111
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
[TBL] [Abstract][Full Text] [Related]
12. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
13. [Medulloblastoma].
Yamaguchi S; Fujimura M
No Shinkei Geka; 2023 Sep; 51(5):858-866. PubMed ID: 37743337
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
15. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
Sadighi Z; Vats T; Khatua S
J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma: recurrence and metastasis.
Aref D; Croul S
CNS Oncol; 2013 Jul; 2(4):377-85. PubMed ID: 25054581
[TBL] [Abstract][Full Text] [Related]
18. The therapy of infantile malignant brain tumors: current status?
Kalifa C; Grill J
J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
[TBL] [Abstract][Full Text] [Related]
19. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.
Lhermitte B; Blandin AF; Coca A; Guerin E; Durand A; Entz-Werlé N
Neurochirurgie; 2021 Feb; 67(1):39-45. PubMed ID: 29776650
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
